MZMiao Zhang

Miao Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miao Zhang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Junbo Zhao

    Department of Forensic Toxicology, Academy of Forensic Science, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform, Key Laboratory of Forensic Sciences Ministry of Justice Shanghai China

    4 shared publications
  • Ping Xiang

    Department of Forensic Toxicology, Academy of Forensic Science, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai, 200063, China

    3 shared publications
  • Hui Yan

    Department of Forensic Toxicology, Shanghai Key Laboratory of Forensic Medicine, Academy of Forensic Science, Shanghai 200063, China

    2 shared publications
  • Jialin Feng

    School of Pharmacy Shenyang Pharmaceutical University Shenyang China

    2 shared publications
  • Hang Chen

    Shanghai Standardization Innovation Center (Forensic Science), Shanghai, China; Department of Forensic Toxicology, Shanghai Key Laboratory of Forensic Medicine, Academy of Forensic Science, Shanghai 200063, China

    1 shared publication
  • Hao Chen

    Shanghai Key Laboratory of Forensic Medicine, Academy of Forensic Science, No. 1347 Guangfuxi Road, Shanghai 200063, People’s Republic of China

    1 shared publication

Latest Publications

  • One blotter stamp: Identification of multiple phenethylamine new psychoactive substances and unambiguous differentiation of two isomers

    by Jialin Feng, Miao Zhang, Ping Xiang, Miao Yu, Junbo Zhao

    In recent years, new psychoactive substances (NPSs) have emerged continuously, often concealed in carriers such as blotter stamps, tobacco, and beverages, posing serious challenges to drug control and forensic identification. In this study, seven phenethylamine substances were detected from a seized blotter stamp using liquid chromatography–high‐resolution mass spectrometry (LC‐HRMS). By comparison with an in‐house mass spectral library, six of them were identified as 25D‐NBOMe, 25E‐NBOH, 25C‐NBOMe, 2C‐E, 25B‐NBOMe, and 25I‐NBOH. The most abundant component exhibited a protonated molecular ion ([M + H] + ) at m/z 330.2068; the relative peak area percentage of this component among the seven identified analytes was approximately 94.6%. Further comparison with the in‐house library indicated that this substance could be either 25G‐NBOMe or 25E‐NBOMe, which were structural isomers of each other. Conventional liquid chromatography–tandem mass spectrometry (LC–MS/MS) methods relying primarily on retention time and selected parent/product ion pairs were insufficient to confidently distinguish these two structural isomers, posing a risk of misidentification. Therefore, this study employed HRMS combined with diagnostic fragment ion abundance ratio analysis. It was found that under identical collision energy conditions, the fragment ions at m/z 135.0804 and 193.1223 exhibited markedly stronger responses for 25E‐NBOMe than for 25G‐NBOMe. Based on this, we distinguished the two structural isomers and confirmed that the target substance in the seized blotter stamp was 25E‐NBOMe.

  • Structural Characterization of 4‐Fluorometomidate: A Novel Metomidate Derivative Detected in an E‐Cigarette

    by Jialin Feng, Xin Wang, Miao Zhang, Ping Xiang, Junbo Zhao

    The nonmedical use of etomidate and its structural analogs as additives in e‐cigarettes has shown a significant growth trend, and the public health and safety risks arising from the abuse of such substances have drawn widespread attention. This study comprehensively employed gas chromatography–mass spectrometry, liquid chromatography–high‐resolution mass spectrometry, and nuclear magnetic resonance spectroscopy (NMR) techniques to identify a novel metomidate analog, 4‐fluorometomidate, in seized cartridges for the first time. Mass spectrometry analysis revealed that under electron ionization conditions, the compound produced fragment ions at m/z 77.1, 95.1, 103.1, 123.1, and 248.1. The molecular ion ( m/z 248.1) and base peak ( m/z 123.1) were both 18 Da higher than the corresponding peaks ( m/z 230.1 and 105.1) characteristic for metomidate. In electrospray ionization mode, its protonated molecule ( m/z 249.1032) also exhibited an increase of 17.9908 Da compared to metomidate ( m/z 231.1124), and the characteristic fragment at m/z 123.0607 showed an increase of 17.9909 Da relative to the fragment of metomidate ( m/z 105.0698), which was overall consistent with the substitution of one hydrogen atom by a fluorine atom (△ m/z 17.9905). NMR analysis confirmed that the fluorine atom is located at the 4′‐position of the benzene ring.


  • In silico metabolite prediction and LC-HRMS confirmation for forensic analysis of a fatal case involving novel synthetic opioid N, N -dimethyl etonitazene

    by Miao Zhang, Jialin Feng, Hang Chen, Ping Xiang, Hui Yan, Junbo Zhao

    Nitazenes are a class of new psychoactive substances (NPS) belonging to the synthetic opioids. It has potent μ-opioid receptor agonist activity. In this study, we investigated an authentic forensic human blood and urine sample from an individual that died from the use of N, N-dimethyl etonitazene. To enable rapid analysis in authentic forensic sample, a method was developed utilizing in silico metabolite prediction and liquid chromatography high-resolution mass spectrometry (LC-HRMS) for blood and urine samples.In this study, LC-HRMS was used to analyze authentic blood and urine samples, and Sygma software was used to predict metabolites. Based on the predicted results, targeted analysis methods of LC-HRMS data were used to study the metabolites of blood and urine. N, N-dimethyl etonitazene and seven metabolites were identified in blood and urine samples. Among them, there were four phase I metabolites, which respectively correspond to four metabolic pathways: N-demethylation (M1), 5-amination (M2), 4′-hydroxylation (M4), N-oxidation (M6). There were three phase II metabolites corresponding to two metabolic pathways, respectively: acetylation (M3), glucuronidation (M5, M7). M1, M2, and M3 were identified in blood sample, and all metabolites were identified in urine sample. In this study, Sygma software was used to predict metabolites, and LC-HRMS method was employed to specifically analyze the metabolites of N, N-dimethyl etonitazene in authentic forensic human samples. The time required for data analysis was significantly reduced through in silico metabolite prediction. We recommend the 5-amination metabolite (M2) as a potential biomarker in blood and urine samples of N, N-dimethyl etonitazene. In addition, this study filled the gap in the study of N, N-dimethyl etonitazene metabolism. It also provided real data supplementation for the metabolism of nitazene analogues. The prediction of metabolites by using Sygma provided a certain reference for the future application of artificial intelligence in the field of forensic analysis.


  • Characterization and Elucidation of the Fragmentation Pathway of 17 Nitazenes by Liquid Chromatography High-Resolution Mass Spectrometry Using Collision-Induced Dissociation and Electron-Activated Dissociation

    by Miao Zhang, Hao Chen, Yiling Tang, Meiting Lin, Ping Xiang, Hui Yan, Junbo Zhao

    Nitazenes, a class of new psychoactive substances, have emerged as a significant public health and safety concern due to their widespread abuse. While various detection methods, particularly mass spectrometry, have been developed for these substances, there is limited information regarding their fragmentation pathways and isomeric identification. This knowledge is crucial for drug analysis and forensic toxicology. Among the mass spectrometry techniques, collision-induced dissociation (CID) is commonly used for analyzing the fragmentation of analytes; however, its fragmentation pattern may not be sufficient for complete characterization or differentiation of isomers. Electron-activated dissociation (EAD), a fragmentation technique, provides complementary data to CID by generating distinct fragment ions that aid in the identification and characterization of small molecules. This study aims to characterize and identify 17 kinds of nitazenes using CID and EAD in combination with liquid chromatography time-of-flight mass spectrometry (LC-TOF-MS). The chromatographic and mass spectrometric behaviors of these compounds were examined, and the fragments were analyzed, with a particular focus on the differences between isomers under CID and EAD modes. Notably, EAD generated more detailed fragmentation profiles than CID, revealing unique fragmentation pathways and characteristic fragment ions. In addition, the doubly charged ions of nitazenes were identified in the EAD spectra. Based on the CID and EAD fragmentation pathways of nitazenes, a novel substance was identified in a seized sample. These findings underscore the value of CID and EAD in enhancing forensic toxicology workflows by providing complementary fragmentation data that improve the identification and characterization of novel and unknown compounds.